The Examiner (Washington, DC)
September 27, 2013
With Congress poised to give the U.S. Food and Drug Administration (FDA) expanded powers over drugs and drugmakers like the one linked to a deadly outbreak of meningitis last year, the public—even Republicans—are clamoring for new regulations.
A new poll from a pro-regulation group found that 73% of Republicans, 83% of Democrats and 70% of independents want compounding pharmacies to be regulated by the FDA, which they aren't today.
Overall, the poll from the Working Group on Pharmaceutical Safety found that 87% want their doctor to tell them when drugs prescribed are non-FDA approved, and 77% are concerned that the FDA isn't doing its job.
The congressional effort comes a year after drugs linked to a specialty Massachusetts drug compounder, New England Compounding Center (NECC), caused a deadly meningitis outbreak. Sixty four people died.
Tommy Thompson, a former secretary of the Department of Health and Human Services, heads the Working Group and said the poll indicates the support Congress has for expanding FDA's regulatory authority over the companies.
"The NECC tragedy and recent troubling findings following inspections of compounding pharmacies underscore the need for the strongest possible legislation that meets the simple and straightforward expectations of voters," said Thompson.
Quality News Today is an ASQ member benefit offering quality related news
from around the world every business day.